Nascent Biotech Inc, based in North Palm Beach, FL, is a biotechnology company specializing in the development of innovative cancer treatments. Their flagship product, Pritumumab, is a proprietary monoclonal antibody that targets a unique antigen found on cancer cells. With FDA orphan drug status, Nascent Biotech is dedicated to advancing the field of oncology and delivering effective therapies for patients.
Through their cutting-edge research and clinical trials, Nascent Biotech aims to revolutionize cancer treatment by harnessing the power of human antibodies. Their commitment to scientific excellence is evident through collaborations with renowned experts on their Science Advisory Board, ensuring the highest standards of innovation and efficacy in their products. Nascent Biotech is poised to make a significant impact in the fight against cancer, offering hope and improved outcomes for patients worldwide.
Generated from the website